Janux Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.15 | $34.61 M | -0.67 | 22 |
KROS
Keros Therapeutics, Inc. |
$13.76 | $558.81 M | -2.75 | 169 |
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$1.33 | $41.55 M | -0.56 | 75 |
EWTX
Edgewise Therapeutics, Inc. |
$14.38 | $1.51 B | -9.9 | 110 |
MLYS
Mineralys Therapeutics, Inc. |
$14.46 | $938.11 M | -3.95 | 51 |
AVTE
Aerovate Therapeutics, Inc. |
$10.09 | $77.68 M | -0.05 | 4 |
HRMY
Harmony Biosciences Holdings, Inc. |
$32.05 | $1.84 B | 12.77 | 268 |
MNOV
MediciNova, Inc. |
$1.52 | $74.55 M | -6.61 | 13 |
FENC
Fennec Pharmaceuticals Inc. |
$6.01 | $166.12 M | -301 | 32 |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 |
RZLT
Rezolute, Inc. |
$3.76 | $304.96 M | -3.05 | 64 |
ADAG
Adagene Inc. |
$1.56 | $59.92 M | -2.15 | 138 |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.10 | $43.55 M | -3.66 | 2 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
CSBR
Champions Oncology, Inc. |
$5.84 | $81.58 M | 13.11 | 210 |
MOLN
Molecular Partners AG |
$4.05 | $150.45 M | -2.12 | 158 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
